August 7, 2008 Home | Print Edition | Close Window

Layoffs on Wall Street... Reverse mortgages... Tweedy, Browne says buy... Blackstone calling the bottom... Ackman's new position...

Goldsmith comment: Dan's traveling, so I'm handling The Digest.

In an effort to trim staff, Wall Street has gotten creative... Goldman Sachs has an "accelerated analyst program." The bank told analysts in its two-year program that they are now on a one-year track.

But American Express may have one-upped Goldman... It's telling employees to get each other fired. According to DealBreaker, "an e-mail went out to all AXP employees that said, paraphrasing, 'As you know, we're in a rough economic environment... so we're launching a campaign called Speak Up and Speak Out, so that you can report on each others' violations without reprieve.'"

Advertisement

Private-equity behemoth Blackstone Group announced earnings yesterday, and the firm says, "We're near a bottom." Blackstone started betting against subprime in 2006, while most investment banks were still poisoning their balance sheets with the debt. The firm started covering its short bets earlier this year, and now it's going long through its "fund of funds" and its credit hedge funds.

Blackstone also bought a minority stake in Bayview Asset Management, a mortgage financing and servicing business that manages a $2 billion mortgage fund. Blackstone joins Lone Star in bullish bets on the mortgage market.

Value investor Tweedy, Browne released its second-quarter letter, and the results are dismal. Traditional value stocks (companies that sell at low price-to-book and price-to-earnings multiples) have been hammered, but Tweedy says its portfolio has "rarely been cheaper than it is today." The firm is urging investors to add to their accounts.

Tweedy also gave away a few interesting stock picks... It has been buying Telecinco, Spain's largest television production company. Telecinco trades at four times pretax earnings, yields 17%, and has net cash on the balance sheet. Tweedy also owns Medikit, a Japanese medical device company trading at 1.6 times pretax earnings, yielding 2.5%, and holding net cash on the balance sheet.

Pershing Square Capital Management, Bill Ackman's hedge fund, announced it owns an 8.8% stake in Longs Drug Stores and may hold talks with the company. The fund said it also bought "total-return swaps" (which allow you to benefit from capital gains without owning an asset) to bring its exposure to about 15.4%. Don't take Ackman's huge position as a buy signal. He's made billions shorting MBIA, Ambac, Fannie, and Freddie, but his long positions, including Borders and Target, have been lacking.

New highs: Baxter (BAX), Barr Pharmaceuticals (BRL), Anheuser-Busch (BUD), Covance (CVD), Wal-Mart (WMT).

We take a momentary break from the venom to ask for your help today...

Dr. David Eifrig is developing our newest service, Retirement Millionaire, and he needs your input. In particular, he wants to know your experiences with reverse mortgages. Have you ever done a reverse mortgage? Have you thought about it? We'd like to hear both success stories and horror stories. Please be as specific as possible. Send them all to feedback@stansberryresearch.com.

"I have been reading your products since 1999 in the Pirate days. The last chairman's letter is certainly among your best works. I enjoyed the read. I am a trader, so I use Jeff Clark's service the most. Some recs have been truly killer... The 'safe' long recommendations from all services also serve me to create a pool of stocks for short put selling over 1 to 3 month time frame. Glad to be a lifetime member." – Paid-up subscriber Terry Easler

Advertisement

"Why don't you come off the Clintons and criticize Bush and his cohorts who have squandered and wasted and stolen billions and who are really responsible for the mess we are in today. Maybe a little reminder when Clinton left office we had a surplus in the budget and now?" – Paid-up subscriber I. Linger

"Your arrogance just astounds me. You are so positive that you are right that you will spout off on all manner of topics that really have nothing to do with anything. Yes, some political issues have to do with investments, the economy. But your tirade re Hillary, for example, has nothing to do with anything that is happening at S&A. Is it really so important to you to spout off your opinions that you will annoy, irk, irritate and alienate a good half of your readers? What is the point? Give it up!" – Paid-up subscriber E. Dean

Goldsmith comment: Give the guy some credit, Dean... Porter annoys, irks, irritates, and alienates at least 75% of our readers.

Regards,

Sean Goldsmith
Baltimore, Maryland
August 7, 2008

Stansberry & Associates Top 10 Open Recommendations

Stock
Sym
Buy Date
Total Return
Pub
Editor
Seabridge
SA
7/6/2005
563.3%
Sjug Conf
Sjuggerud
Humboldt Wedag
KHD
8/8/2003
397.3%
Extreme Val
Ferris
Exelon
EXC
10/1/2002
299.5%
PSIA
Stansberry
EnCana
ECA
5/14/2004
255.8%
Extreme Val
Ferris
Icahn Enterprises
IEP
6/10/2004
254.6%
Extreme Val
Ferris
Crucell
CRXL
3/10/2004
156.2%
Phase 1
Fannon
Valhi
VHI
3/7/2005
144.0%
PSIA
Stansberry
Alnylam
ALNY
 1/16/06
143.6%
Phase 1
Fannon
POSCO
PKX
4/8/2005
141.0%
Extreme Val
Ferris
Alexander & Baldwin
ALEX
10/11/2002
126.8%
Extreme Val
Ferris

Top 10 Totals
5
Extreme Value Ferris
2
PSIA Stansberry
2
Phase 1
Fannon
1
Sjug Conf
Sjuggerud

Stansberry & Associates Hall of Fame

Stock
Sym
Holding Period
Gain
Pub
Editor
JDS Uniphase
JDSU
1 year, 266 days
592%
PSIA Stansberry
Medis Tech
MDTL
4 years, 110 days
333%
Diligence Ferris
ID Biomedical
IDBE
5 years, 38 days
331%
Diligence Lashmet
Texas Instr.
TXN
270 days
301%
PSIA Stansberry
Cree Inc.
CREE
206 days
271%
PSIA Stansberry
Celgene
CELG
2 years, 113 days
233%
PSIA Stansberry
Nuance Comm.
NUAN
326 days
229%
Diligence Lashmet
Airspan Networks
AIRN
3 years, 241 days
227%
Diligence Stansberry
ID Biomedical
IDBE
357 days
215%
PSIA Stansberry
Elan
ELN
331 days
207%
PSIA Stansberry
 
 

Published by Stansberry & Associates Investment Research.

Stansberry & Associates welcomes comments or suggestions at feedback@stansberryresearch.com. This address is for feedback only. For questions about your account or to speak with customer service, call 888-261-2693 (U.S.) or 443-839-0986 (international) Monday-Friday, 9 a.m.-5 p.m. Eastern time. Or e-mail info@stansberrycustomerservice.com. Please note: The law prohibits us from giving personalized investment advice.

© 2012 Stansberry & Associates Investment Research. All rights reserved. Any reproduction, copying, or redistribution, in whole or in part, is prohibited without written permission from Stansberry & Associates, 1217 Saint Paul Street, Baltimore, MD 21202 or www.stansberryresearch.com.

Any brokers mentioned constitute a partial list of available brokers and is for your information only. Stansberry & Associates does not recommend or endorse any brokers, dealers, or investment advisors.

Stansberry & Associates forbids its writers from having a financial interest in any security they recommend to our subscribers. All employees of Stansberry & Associates (and affiliated companies) must wait 24 hours after an investment recommendation is published online – or 72 hours after a direct mail publication is sent – before acting on that recommendation.

This work is based on SEC filings, current events, interviews, corporate press releases, and what we've learned as financial journalists. It may contain errors, and you shouldn't make any investment decision based solely on what you read here. It's your money and your responsibility.